BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24720610)

  • 21. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction.
    Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Yoshida M; Yamashita H; Umemura S; Hori Y; Ohara H; Joh T
    J Gastroenterol Hepatol; 2013 Jan; 28(1):68-72. PubMed ID: 23020651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction.
    Lee KJ; Chung MJ; Park JY; Lee DH; Jung S; Bang BW; Park SW; Chung JB; Song SY; Bang S
    Dig Endosc; 2013 May; 25(3):308-12. PubMed ID: 23369050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palliation of malignant biliary and duodenal obstruction with combined metallic stenting.
    Akinci D; Akhan O; Ozkan F; Ciftci T; Ozkan OS; Karcaaltincaba M; Ozmen MN
    Cardiovasc Intervent Radiol; 2007; 30(6):1173-7. PubMed ID: 17533547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covered metallic stents in the management of malignant and benign pancreatobiliary strictures.
    Isayama H; Nakai Y; Togawa O; Kogure H; Ito Y; Sasaki T; Sasahira N; Hirano K; Tsujino T; Tada M; Kawabe T; Omata M
    J Hepatobiliary Pancreat Surg; 2009; 16(5):624-7. PubMed ID: 19551332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous unilateral placement of biliary covered metallic stent in patients with malignant hilar biliary obstruction and contralateral portal vein occlusion.
    Yi R; Gwon DI; Ko GY; Yoon HK; Kim JH; Shin JH; Sung KB
    Acta Radiol; 2012 Sep; 53(7):742-9. PubMed ID: 22850575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of covered metallic stents in malignant biliary stenosis--prominent effectiveness in gallbladder carcinoma.
    Kawamoto H; Ishida E; Okamoto Y; Okada H; Sakaguchi K; Nakagawa M; Sugihara T; Shiratori Y
    Hepatogastroenterology; 2005; 52(65):1351-6. PubMed ID: 16201072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis.
    Okamoto T; Fujioka S; Yanagisawa S; Yanaga K; Kakutani H; Tajiri H; Urashima M
    Gastrointest Endosc; 2006 May; 63(6):792-6. PubMed ID: 16650540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Recurrent Biliary Obstruction Following Percutaneous Uncovered Metal Stent Insertion in Patients with Distal Malignant Biliary Obstruction: An Analysis Using a Competing Risk Model.
    Zhang JX; Wang B; Liu S; Zu QQ; Shi HB
    Cardiovasc Intervent Radiol; 2019 Feb; 42(2):276-282. PubMed ID: 30411153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer.
    Hamada T; Isayama H; Nakai Y; Togawa O; Kogure H; Kawakubo K; Tsujino T; Sasahira N; Hirano K; Yamamoto N; Arizumi T; Ito Y; Matsubara S; Sasaki T; Yagioka H; Yashima Y; Mohri D; Miyabayashi K; Mizuno S; Nagano R; Takahara N; Toda N; Tada M; Omata M; Koike K
    Gastrointest Endosc; 2011 Sep; 74(3):548-55. PubMed ID: 21794859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of occluded uncovered metallic stents in patients with malignant distal biliary obstructions using covered metallic stents.
    Togawa O; Kawabe T; Isayama H; Nakai Y; Sasaki T; Arizumi T; Matsubara S; Ito Y; Yamamoto N; Sasahira N; Hirano K; Tsujino T; Toda N; Tada M; Yoshida H; Omata M
    J Clin Gastroenterol; 2008; 42(5):546-9. PubMed ID: 18344884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the 14-mm uncovered and 10-mm covered metal stents in patients with distal biliary obstruction caused by unresectable pancreatic cancer: a multicenter retrospective study.
    Satoh T; Ishiwatari H; Kawaguchi S; Shirane N; Matsubayashi H; Kaneko J; Sato J; Ishikawa K; Otsu T; Terada S; Ono H; Kikuyama M
    Surg Endosc; 2022 Jan; 36(1):736-744. PubMed ID: 33591450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent.
    Eum YO; Kim YT; Lee SH; Park SW; Hwang JH; Yoon WJ; Ryu JK; Yoon YB; Han JK; Yoon CJ; Cho JH; Choi Y
    Dig Endosc; 2013 Jan; 25(1):67-75. PubMed ID: 23286259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.
    Aadam AA; Evans DB; Khan A; Oh Y; Dua K
    Gastrointest Endosc; 2012 Jul; 76(1):67-75. PubMed ID: 22483859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of covered metallic stents in the treatment of unresectable malignant biliary obstruction.
    Miyayama S; Matsui O; Akakura Y; Yamamoto T; Nishida H; Yoneda K; Kawai K; Toya D; Tanaka N; Mitsui T; Asada Y
    Cardiovasc Intervent Radiol; 2004; 27(4):349-54. PubMed ID: 15136887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of the WallFlex partially covered stent for unresectable malignant biliary obstruction: a multicenter single-arm prospective study.
    Sakai Y; Tsuyuguchi T; Hirata N; Sugiyama H; Shimura K; Nakaji S; Shiratori T; Fujimoto T; Tsuchiya S; Mikami S; Yokosuka O
    Hepatogastroenterology; 2013; 60(128):1854-60. PubMed ID: 24088309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention.
    Ornellas LC; Stefanidis G; Chuttani R; Gelrud A; Kelleher TB; Pleskow DK
    Gastrointest Endosc; 2009 Oct; 70(4):676-83. PubMed ID: 19560137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migration of retrievable expandable metallic stents inserted for malignant esophageal strictures: incidence, management, and prognostic factors in 332 patients.
    Park JH; Song HY; Shin JH; Cho YC; Kim JH; Kim SH; Park J
    AJR Am J Roentgenol; 2015 May; 204(5):1109-14. PubMed ID: 25905949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients.
    Sakai Y; Iwai T; Shimura K; Gon K; Koizumi K; Ijima M; Chiba K; Nakatani S; Sugiyama H; Tsuyuguchi T; Kamisawa T; Maetani I; Kida M
    World J Gastroenterol; 2018 Jan; 24(1):69-75. PubMed ID: 29358883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prospective Multicenter Study of a Fully Covered Metal Stent in Patients with Distal Malignant Biliary Obstruction: WATCH-2 Study.
    Kogure H; Ryozawa S; Maetani I; Nakai Y; Kawakami H; Yasuda I; Mochizuki H; Iwano H; Maguchi H; Kida M; Kubota K; Mukai T; Hasebe O; Igarashi Y; Hanada K; Irisawa A; Ito K; Itoi T; Isayama H
    Dig Dis Sci; 2018 Sep; 63(9):2466-2473. PubMed ID: 29218484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of stent occlusion in patients with unresectable pancreatic cancer after biliary metal stents.
    Lin XH; Ting PH; Luo JC; Lee KC; Chen TS; Huang YH; Hou MC; Lee FY
    J Chin Med Assoc; 2019 Oct; 82(10):762-766. PubMed ID: 31356569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.